Macroscopically, the 5 cm ulcerated tumor was located in the antral and pyloric transition region with an irregular border. Microscopically, it was composed of moderate to severe cytological atypical carcinoma cells, arranged in micropapillary structures. In superficial areas of ulcerated mass, transition from classical adenocarcinoma to IMPC areas were seen abruptly (Figure 1). However over 90% of the tumor was composed of micropapillary structures (Figure 2) except for several foci of poorly differentiated adenocarcinoma. Neoplastic cells invaded the muscularis propria and subserosal adipose tissue and also foci of lymphatic invasion were observed. Two of two lymph nodes along the greater curvature, and six of nine lymph nodes along the lesser curvature revealed metastases composed of a mixture of micropapillary and conventional adenocarcinoma morphologically contrary to primary tumor (Figure 3).
Neoplastic cells of micropapillary and conventional adenocarcinoma components were diffusely positive for pancytokeratin, cytokeratin 7 (CK7) and EMA. On the contrary of the positivity of EMA that was predominantly observed in luminal surface and cytoplasm of glandular structures in ordinary adenocarcinoma areas; outside membranous and peripheral cytoplasmic positivity were seen in micropapillary areas (Figure 4). This kind of staining pattern is called “inside-out polarity” and is considered highly characteristic for micropapillary carcinoma. The possibility of fixation artefact versus vessel invasion was verified by CD34 and factor VIII related antigen negativity. Results of other immunohistochemical antibodies were given in Table I. Approximately 35% of the neoplastic cells were positive for Ki-67 antigen.
The main differential diagnosis of primary IMPC of the stomach is conventional gastric carcinomas showing extensive lymphatic invasion or metastatic invasive micropapillary carcinomas[8]. In our case, lymphovascular invasions have been ruled out with CD34 negativity in lining cells in inner surface of spaces. We used three criteria to distinguish the primary IMPC from a metastatic carcinoma. Firstly, the presence of foci of ordinary adenocarcinoma originated from the gastric mucosa and the transition between classical adenocarcinoma and IMPC areas. Secondly, absence of any radiologically detected solitary or multiple masses compatible with possible primary focus. And finally, immunohistochemical staining profile of neoplastic cells which demonstrated CK7 positivity, CK20, estrogen, progesteron, GCDFP-15 and cerbB-2 negativity pointing out the stomach as the most possible primary site. Clinicopathological stage of stomach IMPC is usually reported to be higher, that most of the patients have invasion in gastric subserosal tissue in addition to muscularis propria invasion and lymph node metastasis similar to our case[7-10]. But, on the contrary, Roh et al. suggested that the prognosis of the patients with IMPC of the stomach were not different than the patients with ordinary adenocarcinoma of the stomach[11]. Our patient was under follow-up without any therapy due to major cardiovascular problems. Although a minimum increase of the CEA level (CEA:39.26 mg/dl. to 43.19 mg/ dl.) was observed in blood during follow-up, the patient remained alive without further metastasis for eight months, after the operation. But it is very early to judge about the survival of the case for the limited follow up period.
The E-cadherin gene has been described as an invasionsuppressor gene[12] and the loss of E-cadherin expression is considered to be associated with tumor invasion in gastric adenocarcinomas. E-cadherin loss has also been reported in primary gastric IMPC and one of the reported case also had a 23.5 % Ki-67 expression rate as a predictive marker of poor prognosis[12,13]. In our case, loss of E-cadherin expression was observed in both IMPC and poorly differentiated component of the tumor similar to reported by Shimoda et al[8]. Ki-67 index was 35% in neoplastic cells and was similar again to results published in literature. Agressive nature and high morbidity and mortality ratio of the entity in stomach were also described in a recently published paper by Ushiku et. al[14]. However larger series with IMPC component is necessary to determine the actual importance of the ratio of IMPC component and its impact on the prognosis of gastric cancer.
In conclusion, the diagnosis of IMPC should be kept in mind and needs to be carefully analyzed to understand its etiopathogenesis and effect on clinical behaviour.
1) Tavassoli F, Devilee P. WHO Classification of Tumours, Pathology
and Genetics. Tumour of the Breast and Female Genital Organs.
Lyon: IARC Press; 2003.
2) Siriaunkgul S, Tavassoli FA. Invasive micropapillary carcinoma of
the breast. Mod Pathol. 1993;6:660-2.
3) Amin MB, Ro JY, el-Sharkawy T, Lee KM, Troncoso P, Silva EG,
Ordóñez NG, Ayala AG. Micropapillary variant of transitional
cell carcinoma of the urinary bladder. Histologic pattern
resembling ovarian papillary serous carcinoma. Am J Surg Pathol.
1994;18:1224-32.
4) Johansson SL, Borghede G, Holmang S. Micropapillary bladder
carcinoma: A clinicopathological study of 20 cases. J Urol. 1999;
161:1798-802.
5) Sakamoto K, Watanabe M, De La Cruz C, Honda H, Ise H,
Mitsui K, Namiki K, Mikami Y, Moriya T, Sasano H. Primary
invasive micropapillary carcinoma of the colon. Histopathology.
2005;47:479-84.
6) Nagao T, Gaffey TA, Visscher DW, Kay PA, Minato H, Serizawa
H, Lewis JE. Invasive micropapillary salivary duct carcinoma: A
distinct histologic variant with biologic significance. Am J Surg
Pathol. 2004;28:319-26.
7) Kondo T, Kitazawa R, Kitazawa S. Gastric remnant
adenocarcinoma with micropapillary component. Dig Dis Sci.
2008;53:2287-9.
8) Shimoda M, Okada Y, Hayashi Y, Hatano S, Kawakubo H, Omori
T, Ishii S, Sugiura H. Primary invasive micropapillary carcinoma
of the stomach. Pathol Int. 2008;58:513-7.
9) Eom DW, Kang GH, Han SH. Cheon GJ, Han KH, Oh HS, Kim
JH, Jang HJ, Hong SM. Gastric micropapillary carcinoma: A
distinct subtype with a significantly worse prognosis in TNM
stages I and II. Am J Surg Pathol. 2011;35:84-91.
10) Lee JH, Kim JH, Choi JW, Kim YS. The presence of a micropapillary
component predicts aggressive behaviour in early and advanced
gastric adenocarcinomas. Pathology. 2010;42: 560-3.
11) R oh JH, Srivastava A, Lauwers GY, An J, Jang KT, Park CK, Sohn
TS, Kim S, Kim KM. Micropapillary Carcinoma of Stomach A
Clinicopathologic and Immunohistochemical Study of 11 Cases.
Am J Surg Pathol. 2010;34:1139-46.
12) Yonemura Y, Ninomiya I, Kaji M Sugiyama K, Fujimura T,
Tsuchihara K, Kawamura T, Miyazaki I, Endou Y, Tanaka M.
Decreased E-cadherin expression correlates with poor survival in
patients with gastric cancer. Anal Cell Pathol. 1995;8:177-190.